0001209191-18-045692.txt : 20180807 0001209191-18-045692.hdr.sgml : 20180807 20180807164604 ACCESSION NUMBER: 0001209191-18-045692 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180803 FILED AS OF DATE: 20180807 DATE AS OF CHANGE: 20180807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18998725 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2018-08-03 4 M 0 2330 86.52 A 41939 D Common Stock 2018-08-03 4 S 0 2330 174.20 D 39609 D Stock Option (Right to Buy) 86.52 2018-08-03 4 M 0 2330 0.00 D 2027-02-02 Common Stock 2330 23299 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 2/3/2017. /s/ Stephen Migausky, Attorney-in-Fact 2018-08-07